ArticleJNCI cancer spectrum2019
Mapping the Global Cancer Research Funding Landscape.
Article in JNCI cancer spectrum, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- The International Agency for Research on Cancer: from global evidence to national action.The Lancet. Public health · 2026Review
- Global research landscape of retinoblastoma biomarkers: a multidisciplinary bibliometric analysis based on multiple databases (2005-2025).Journal of cancer research and clinical oncology · 2025Article
- Cancer Research Funding in Africa.Communications medicine · 2025Article
- Cancer research funding in South Asia.Journal of cancer policy · 2024Article
- Technology-based interventions for tobacco smoking prevention and treatment: a 20-year bibliometric analysis (2003-2022).Substance abuse treatment, prevention, and policy · 2024Article
- Mapping the European cancer prevention research landscape: A case for more prevention research funding.European journal of cancer (Oxford, England : 1990) · 2023Article
- The role of the private sector in noncommunicable disease prevention and management in low- and middle-income countries: a series of systematic reviews and thematic syntheses.International journal of qualitative studies on health and well-being · 2023Review
- Computational pathology in cancer diagnosis, prognosis, and prediction - present day and prospects.The Journal of pathology · 2023Review
- An analysis of the African cancer research ecosystem: tackling disparities.BMJ global health · 2023Article
- Do funding sources complement or substitute? Examining the impact of cancer research publications.Journal of the Association for Information Science and Technology · 2023Article
- Article
- Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine.European urology open science · 2021Article
- The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research.The Lancet. Oncology · 2021Review
- Epidemiology and genomics of prostate cancer in Asian men.Nature reviews. Urology · 2021Review
- Trends in International Cancer Research Investment 2006-2018.JCO global oncology · 2021Article
- Getting to the bottom of research funding: Acknowledging the complexity of funding dynamics.PloS one · 2021Article
- Who Actually Funds Cancer Research?JNCI cancer spectrum · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundGlobal investment in research on noncommunicable diseases is on the rise. Cancer as primus inter pares draws particular interest from a wide spectrum of research funders. Next to the private, governmental, and academic sectors, philanthropy has carved out a sizeable area in the funding landscape over the last 25 years. Previous reports describing cancer research funding have looked at the volume of investment in cancer research but have paid little attention to building strategic intelligence on funders. Moreover, these efforts have focused primarily on well-resourced organizations, neglecting a large number of players with less-developed finances.
methodsIn this article, we combined gnostic data acquisition with agnostic bibliometrics to establish a comprehensive map of the global cancer research funding landscape. The analysis of funding acknowledgments from cancer research papers used in this exercise is a "bottom-up" method that provides a broader perspective on the variety of actors involved. It does not rely on a priori knowledge, nor does it require funders' support for access to the data.
resultsUsing this approach, we have identified a total of 4693 organizations from 107 countries engaged in funding cancer research today.
conclusionsThis is the largest mapping exercise performed to date and should serve as a knowledge base for future analyses and comparisons aimed at understanding the dynamics and priorities of global cancer research funding.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.